Executive Management
| Martin D. Madaus, Ph.D | Chairman of the Board, President, CEO |
| Charles F. Wagner, Jr. | Corporate VP and Chief Financial Officer |
| Dominique F. Baly | President, Bioscience Division |
| Jean-Paul Mangeolle | President, Bioprocess Division |
| Dennis Harris | Corporate VP, Chief Scientific Officer |
| Geoffrey Ide | Corporate VP, International Markets |
| Jeffrey Rudin | Corporate VP, General Counsel, Secretary |
| Peter Kershaw | Corporate VP, Global Supply Chain |
| Bruce Bonnevier | Corporate VP, Global Human Resources |
| Gregory J. Sam | Corporate VP, Corporate Quality |
IR Contact
Contact for shareholders, potential investors and financial media.
Joshua S. Young
Director, Investor Relations
Tel: 978-715-1527
Joshua_Young@millipore.com
IR Services
Sign up for company alerts and download reports.
Safe Harbor Statement
The information on the Millipore investor relations website, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.
» More
